Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency
Crossref DOI link: https://doi.org/10.1007/s13318-016-0334-5
Published Online: 2016-04-21
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bokemeyer, Bernd
Krummenerl, Annette
Maaser, Christian
Howaldt, Stefanie
Mroß, Michael
Mallard, Nick
Funding for this research was provided by:
Iron Therapeutics (UK) Ltd
Text and Data Mining valid from 2016-04-21